| Company | Share, % |
|---|---|
 MedAvail Holdings, Inc.
|
42.88 |
| ADC Therapeutics SA | 18.57 |
 Fate Therapeutics
|
13.27 |
 Shattuck Labs, Inc.
|
11.84 |
 Zymeworks Inc.
|
9.19 |
 IGM Biosciences, Inc.
|
8.93 |
 Epizyme, Inc.
|
8.33 |
 Scholar Rock Holding Corporation
|
8.22 |
 Immunome
|
8.15 |
| Lava Therapeutics B.V. | 7.89 |
 REGENXBIO
|
7.67 |
 Atara Biotherapeutics
|
7.63 |
 ALX Oncology Holdings Inc.
|
7.3 |
| Absci Corporation | 7.3 |
 Annexon, Inc.
|
7.02 |
 ImmunoGen
|
6.57 |
 Replimune Group, Inc.
|
6.3 |
 Neoleukin Therapeutics, Inc.
|
6.2 |
 Krystal Biotech, Inc.
|
6.08 |
 Gritstone Oncology, Inc.
|
5.99 |
| Category | Quantity |
|---|---|
| Healthcare | 43 |
